ObjectiveThis study aims to find whether microRNAs (miRNAs) detected in the culture
medium of embryos produced in vitro could be potential biomarkers of embryo
implantation.MethodsCulture media samples from 36 embryos, derived from patients undergoing
intracytoplasmic sperm injection (ICSI) in a private university-affiliated
IVF center, were collected between January/2015 and November/2015. Samples
were collected on day three and embryo transfers were performed on day five
and all embryos reached the blastocyst stage. Samples were split into groups
according to the embryo implantation result: Positive-Implantation-Group
(n=18) or Negative-Implantation-Group (n=18). For the first analysis,
samples were pooled in three sets for each group (6-7 spent media per pool).
MicroRNAs were extracted from spent media and cDNA was synthesized. C.
elegans miR-39 was used as RNA spike-in to normalize the
gene expression analysis. The expression of microRNAs into the spent media
from the Positive-Implantation-Group was compared with those from the
Negative-Implantation-Group. A set of seven miRNAs (miR-21,
miR-142-3p, miR-19b, miR-92a, miR-20b, miR-125a and miR148a)
selected according with the literature, was tested. To check whether miRNAs
could be detected in individual samples of culture media, in a second
analysis, ten more samples were tested for miR-21 and
miR-142-3p.ResultsFrom the sevens tested miRNAs, a significant increased expression of
miR-142-3p could be noted in the Negative-Implantation-Group
(P<0.001). For other three miRNAs (miR-21,
miR-19b and miR-92a) a difference in
expression was observed, however it did not reach a statistical
significance. In addition, when ten non-redundant samples were tested to
check if miRNAs could be detected in individual samples of culture media,
the highly specific amplification of mature miRNAs, including
miR-142-3p, could be noted.ConclusionOur findings suggest that miR-142-3p, previously described
as a tumor suppressor and cell cycle inhibitor, may be a potential biomarker
of blastocyst implantation failure. The identification of miRNAs on
individual culture medium samples offers unique opportunities for
non-invasive early diagnosis of blastocyst implantation.